Quest Diagnostics Incorporated (DGX) Investor Relations Documents

Quest Diagnostics Incorporated (DGX) investor relations documents from the company's IR site: 3 presentations, 36 press releases; latest deck 2026-02-10. Read in-app with summaries. First-party data.

supplemental Open Event Link, PDF file, 02/10/2026, (opens in new window): Quest Diagnostics Q4 2025 earnings report shows $2.81 billion in quarterly revenue and full-year 2025 revenue of $11.04 billion with 7.1% Q4 growth.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-07-08Press releaseQuest Diagnostics Now the Largest Clinical Reference Lab to Extend Oncology Test Access Through OncoEMR MPI
2026-06-24Press releaseQuest Diagnostics Receives New York State Approval for Haystack MRD®, Broadening Patient Access to ctDNA Minimal Residua
2026-06-18Press releaseDownload , UTI-causing Bacteria Resistant to Current Drugs, Finds National Study by Hackensack Meridian CDI and Quest Di
2026-06-17Press releaseDownload , Quest Diagnostics to Release Second Quarter Financial Results on July 23, 2026, 06/17/2026, (opens in new win
2026-06-17Press releaseQuest Diagnostics to Release Second Quarter Financial Results on July 23, 2026
2026-06-16Press releaseDownload , Quest Diagnostics Unveils Achievements in Healthcare Access, Employee Engagement and Environmental Sustainabi
2026-06-16Press releaseQuest Diagnostics Unveils Achievements in Healthcare Access, Employee Engagement and Environmental Sustainability in 202
2026-05-19Press releaseDownload , Quest Diagnostics Declares Quarterly Cash Dividend, 05/19/2026, (opens in new window)
2026-05-19Press releaseQuest Diagnostics Declares Quarterly Cash Dividend
2026-04-27Press releaseDownload , Quest Diagnostics Prices $500 Million of Senior Notes, 04/27/2026, (opens in new window)
2026-04-27Press releaseQuest Diagnostics Prices $500 Million of Senior Notes
2026-04-21Press releaseQuest Diagnostics Reports First Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026
2026-04-21Press releaseDownload , Quest Diagnostics Reports First Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year
2026-04-16Press releaseDownload , City of Hope to Evaluate Quest Diagnostics' Haystack MRD® for Guiding Patient Management in Multiple Cancers,
2026-04-16Press releaseCity of Hope to Evaluate Quest Diagnostics' Haystack MRD® for Guiding Patient Management in Multiple Cancers
2026-03-19Press releaseDownload , Quest Diagnostics to Release First Quarter Financial Results on April 21, 2026, 03/19/2026, (opens in new win
2026-02-25Press releaseDownload , Quest Diagnostics to Speak at the Leerink 2026 Global Healthcare Conference, 02/25/2026, (opens in new window
2026-02-10Earnings decksupplemental Open Event Link, PDF file, 02/10/2026, (opens in new window)
2026-02-10Press releaseDownload , Quest Diagnostics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Guidance for Full Yea
2026-02-10Press releaseQuest Diagnostics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Guidance for Full Year 2026; Inc
2026-02-02Press releaseDownload , Quest Diagnostics Launches Novel Flow Cytometry MRD Blood Test for Myeloma, Enabling Ultrasensitive Detection
2026-01-08Press releaseDownload , Quest Diagnostics to Release Fourth Quarter and Full Year 2025 Financial Results on February 10, 2026, 01/08/
2026-01-08Press releaseQuest Diagnostics to Release Fourth Quarter and Full Year 2025 Financial Results on February 10, 2026
2026-01-06Press releaseDownload , Data Featuring Haystack MRD® from Quest Diagnostics to be Presented at the 2026 ASCO Gastrointestinal Cancers
2026-01-05Press releaseDownload , Corewell Health and Quest Diagnostics Complete Laboratory Joint Venture Transaction in Michigan, 01/05/2026,
2025-10-21Earnings deckQ3
2025-07-22Press releaseQ2
2025-04-22Press releaseQ1
2025-03-19PresentationDownload PDF file, (opens in new window)
2025-01-30Press releaseQ4
2024-10-22Press releaseQ3
2024-07-23Press releaseQ2
2024-04-23Press releaseQ1
2024-02-01Press releaseQ4
2023-10-24Press releaseQ3
2023-07-26Press releaseQ2
2023-04-27Press releaseQ1
2023-02-22Financial supplementQ4
2023-02-02Press releaseQ4
2022-10-20Press releaseQ3

DGX overview · DGX earnings · DGX financials · DGX KPIs · DGX documents · DGX ownership · DGX peers

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.